| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
100 |
| issn |
1543-0790 |
| issueIdentifier |
2 |
| pageRange |
98-100 |
| publicationName |
Clinical advances in hematology & oncology : H&O |
| startingPage |
98 |
| bibliographicCitation |
Sledge GW. Advances in HER2-positive breast cancer. Clin Adv Hematol Oncol. 2008 Feb;6(2):98–100. PMID: 18347559. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12f8eecde129d6e5c140a559a5dfa286 |
| date |
200802 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/18347559 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1543-0790
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32465 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Advances in HER2-positive breast cancer |
| discusses |
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0466011
http://id.nlm.nih.gov/mesh/M0500817
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0291428
http://id.nlm.nih.gov/mesh/M0473129 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D018719Q000187
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D001943Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077341
http://id.nlm.nih.gov/mesh/D011799Q000008
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D001943Q000235
http://id.nlm.nih.gov/mesh/D000068878
http://id.nlm.nih.gov/mesh/D066246Q000187 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |